NASOPHARYNGITIS

Adverse reaction reported in 243,044 FDA reports across 77 drugs.

243,044
Total Reports
77
Drugs Involved
Adalimumab
Most Reported Drug

Drugs Associated with NASOPHARYNGITIS

Drugs where "NASOPHARYNGITIS" was reported as an adverse event.

# Drug Reports % of Total
1 Adalimumab 20,734
8.5%
2 Etanercept 20,724
8.5%
3 Prednisone 14,866
6.1%
4 Methotrexate 14,273
5.9%
5 Acetaminophen 12,812
5.3%
6 Ergocalciferol 9,609
4.0%
7 Folic Acid 9,463
3.9%
8 Pain Reliever 9,139
3.8%
9 Tofacitinib 8,809
3.6%
10 Secukinumab 7,647
3.1%
11 Ibuprofen 6,699
2.8%
12 Acetaminophen, Guaifenesin, / Phenylephrine Hydrochloride 5,691
2.3%
13 Ibupfrofen 5,654
2.3%
14 Natalizumab 4,474
1.8%
15 Calcium 4,236
1.7%
16 Methylprednisolone 3,920
1.6%
17 Omalizumab 3,914
1.6%
18 Hydrocortisone 3,630
1.5%
19 Vitamin C 3,578
1.5%
20 Apremilast 3,278
1.3%
21 Naproxen 2,978
1.2%
22 Cetiirizine 2,947
1.2%
23 Budesonide / Formoterol Fumarate Dihydrate 2,768
1.1%
24 Tiotropium Bromide 2,715
1.1%
25 Diphenhydramine 2,638
1.1%
26 Ambrisentan 2,633
1.1%
27 Ocrelizumab 2,549
1.0%
28 Evolocumab 2,539
1.0%
29 Vedolizumab 2,445
1.0%
30 Fish Oil 2,414
1.0%
31 Mepolizumab 2,178
0.9%
32 Epinephrine 2,151
0.9%
33 Fluticasone Propionate / Salmeterol Xinafoate 2,127
0.9%
34 Fingolimod 2,038
0.8%
35 Infliximab-Dyyb 1,924
0.8%
36 Pomalidomide 1,654
0.7%
37 Adrenalinum 1,636
0.7%
38 Oxybate 1,553
0.6%
39 Upadacitinib 1,543
0.6%
40 Mesalamine 1,489
0.6%
41 Acetaminophen / Codeine 1,445
0.6%
42 Chlorhexidine Gluconate 1,435
0.6%
43 Eculizumab 1,326
0.5%
44 Risankizumab-Rzaa 1,308
0.5%
45 Ofatumumab 1,241
0.5%
46 Mometasone Furoate 1,169
0.5%
47 Mirabegron 1,101
0.5%
48 Human Immunoglobulin G 1,088
0.4%
49 Cyanocobalamin 1,040
0.4%
50 Ciclesonide 1,021
0.4%
51 Aprepitant 822
0.3%
52 Doxyclycline Hyclate 790
0.3%
53 Biotin 777
0.3%
54 Dimenhydrinate 718
0.3%
55 Zinc Gluconate 706
0.3%
56 Guaifenesin 674
0.3%
57 Zinc 672
0.3%
58 Ixekizumab 643
0.3%
59 Palivizumab 638
0.3%
60 Alirocumab 584
0.2%
61 Naproxen Sodium, Pseudoephedrine Hydrochloride 564
0.2%
62 Naproxen Sodium, Dextromethorphan Hydrobromide, Guaifenesin 564
0.2%
63 Rabeprazole 562
0.2%
64 Mometasone 542
0.2%
65 Telmisartan 522
0.2%
66 Benzonatate 409
0.2%
67 Azelastine 383
0.2%
68 Dornase Alfa 380
0.2%
69 Bimekizumab 282
0.1%
70 Elexacaftor, Tezacaftor, / Ivacaftor 251
0.1%
71 Ravulizumab 235
0.1%
72 Colesevelam 213
0.1%
73 Ado-Trastuzumab Emtansine 208
0.1%
74 Lumacaftor / Ivacaftor 202
0.1%
75 Umeclidinium 176
0.1%
76 Ivacaftor 170
0.1%
77 Eptinezumab-Jjmr 114
0.0%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. The presence of a drug in this list does not mean the drug caused nasopharyngitis. Always consult your healthcare provider.